UniProt ID | BCKD_HUMAN | |
---|---|---|
UniProt AC | O14874 | |
Protein Name | [3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial | |
Gene Name | BCKDK | |
Organism | Homo sapiens (Human). | |
Sequence Length | 412 | |
Subcellular Localization | Mitochondrion matrix. Mitochondrion . | |
Protein Description | Catalyzes the phosphorylation and inactivation of the branched-chain alpha-ketoacid dehydrogenase complex, the key regulatory enzyme of the valine, leucine and isoleucine catabolic pathways. Key enzyme that regulate the activity state of the BCKD complex.. | |
Protein Sequence | MILASVLRSGPGGGLPLRPLLGPALALRARSTSATDTHHVEMARERSKTVTSFYNQSAIDAAAEKPSVRLTPTMMLYAGRSQDGSHLLKSARYLQQELPVRIAHRIKGFRCLPFIIGCNPTILHVHELYIRAFQKLTDFPPIKDQADEAQYCQLVRQLLDDHKDVVTLLAEGLRESRKHIEDEKLVRYFLDKTLTSRLGIRMLATHHLALHEDKPDFVGIICTRLSPKKIIEKWVDFARRLCEHKYGNAPRVRINGHVAARFPFIPMPLDYILPELLKNAMRATMESHLDTPYNVPDVVITIANNDVDLIIRISDRGGGIAHKDLDRVMDYHFTTAEASTQDPRISPLFGHLDMHSGAQSGPMHGFGFGLPTSRAYAEYLGGSLQLQSLQGIGTDVYLRLRHIDGREESFRI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
31 | Phosphorylation | ALALRARSTSATDTH HHHHHCCCCCCCCCH | 26.23 | 22167270 | |
32 | Phosphorylation | LALRARSTSATDTHH HHHHCCCCCCCCCHH | 19.48 | 22167270 | |
33 | Phosphorylation | ALRARSTSATDTHHV HHHCCCCCCCCCHHH | 30.34 | 22167270 | |
35 | Phosphorylation | RARSTSATDTHHVEM HCCCCCCCCCHHHHH | 40.99 | 22167270 | |
37 | Phosphorylation | RSTSATDTHHVEMAR CCCCCCCCHHHHHHH | 14.99 | 23927012 | |
47 | Phosphorylation | VEMARERSKTVTSFY HHHHHHHHCCHHHHC | 28.11 | - | |
48 | Ubiquitination | EMARERSKTVTSFYN HHHHHHHCCHHHHCC | 53.92 | 21890473 | |
48 | Ubiquitination | EMARERSKTVTSFYN HHHHHHHCCHHHHCC | 53.92 | 21890473 | |
48 | Ubiquitination | EMARERSKTVTSFYN HHHHHHHCCHHHHCC | 53.92 | 21890473 | |
52 | Phosphorylation | ERSKTVTSFYNQSAI HHHCCHHHHCCHHHH | 22.77 | 19060867 | |
57 | Phosphorylation | VTSFYNQSAIDAAAE HHHHCCHHHHHHHHC | 24.45 | 28857561 | |
71 | Phosphorylation | EKPSVRLTPTMMLYA CCCCCEECCCEEEEC | 13.22 | 29978859 | |
73 | Phosphorylation | PSVRLTPTMMLYAGR CCCEECCCEEEECCC | 15.24 | 29978859 | |
77 | Phosphorylation | LTPTMMLYAGRSQDG ECCCEEEECCCCCCH | 6.79 | 25884760 | |
81 | Phosphorylation | MMLYAGRSQDGSHLL EEEECCCCCCHHHHH | 31.53 | 28857561 | |
85 | Phosphorylation | AGRSQDGSHLLKSAR CCCCCCHHHHHHHHH | 21.17 | 29978859 | |
89 | Acetylation | QDGSHLLKSARYLQQ CCHHHHHHHHHHHHH | 48.72 | 25953088 | |
89 | Methylation | QDGSHLLKSARYLQQ CCHHHHHHHHHHHHH | 48.72 | - | |
90 | Phosphorylation | DGSHLLKSARYLQQE CHHHHHHHHHHHHHH | 20.25 | 29978859 | |
93 | Phosphorylation | HLLKSARYLQQELPV HHHHHHHHHHHHCCH | 14.47 | 28152594 | |
184 | Acetylation | RKHIEDEKLVRYFLD HHHCCHHHHHHHHHH | 65.68 | 19608861 | |
184 | Succinylation | RKHIEDEKLVRYFLD HHHCCHHHHHHHHHH | 65.68 | 23954790 | |
192 | Acetylation | LVRYFLDKTLTSRLG HHHHHHHHHHHHHHH | 47.80 | 19608861 | |
192 | Acetylation | LVRYFLDKTLTSRLG HHHHHHHHHHHHHHH | 47.80 | - | |
192 | 2-Hydroxyisobutyrylation | LVRYFLDKTLTSRLG HHHHHHHHHHHHHHH | 47.80 | - | |
226 | Phosphorylation | GIICTRLSPKKIIEK EEEECCCCHHHHHHH | 31.23 | 26091039 | |
233 | Acetylation | SPKKIIEKWVDFARR CHHHHHHHHHHHHHH | 41.95 | 19608861 | |
245 | Acetylation | ARRLCEHKYGNAPRV HHHHHHHHCCCCCEE | 32.34 | 19608861 | |
246 | Phosphorylation | RRLCEHKYGNAPRVR HHHHHHHCCCCCEEE | 19.95 | - | |
284 | Phosphorylation | LKNAMRATMESHLDT HHHHHHHHHHHHCCC | 15.88 | 22210691 | |
287 | Phosphorylation | AMRATMESHLDTPYN HHHHHHHHHCCCCCC | 20.66 | 22210691 | |
301 | Phosphorylation | NVPDVVITIANNDVD CCCCEEEEEECCCCE | 11.48 | 22210691 | |
331 | Phosphorylation | DLDRVMDYHFTTAEA CHHHHHHEEEECHHC | 4.82 | 23312004 | |
334 | Phosphorylation | RVMDYHFTTAEASTQ HHHHEEEECHHCCCC | 16.28 | 28857561 | |
335 | Phosphorylation | VMDYHFTTAEASTQD HHHEEEECHHCCCCC | 22.89 | 28857561 | |
339 | Phosphorylation | HFTTAEASTQDPRIS EEECHHCCCCCCCCC | 20.36 | 28857561 | |
340 | Phosphorylation | FTTAEASTQDPRISP EECHHCCCCCCCCCH | 44.00 | 28857561 | |
356 | Phosphorylation | FGHLDMHSGAQSGPM CCCCCCCCCCCCCCC | 29.23 | 24719451 | |
360 | Phosphorylation | DMHSGAQSGPMHGFG CCCCCCCCCCCCCCC | 44.31 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
246 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BCKD_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BCKD_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CAB39_HUMAN | CAB39 | physical | 17353931 | |
CB39L_HUMAN | CAB39L | physical | 17353931 | |
ODBA_HUMAN | BCKDHA | physical | 17353931 | |
RN219_HUMAN | RNF219 | physical | 17353931 | |
FA98B_HUMAN | FAM98B | physical | 17353931 | |
RTCA_HUMAN | RTCA | physical | 17353931 | |
A4_HUMAN | APP | physical | 21832049 | |
STAT3_HUMAN | STAT3 | physical | 21988832 | |
EPS8_HUMAN | EPS8 | physical | 21988832 | |
LSM8_HUMAN | LSM8 | physical | 21988832 | |
CETN3_HUMAN | CETN3 | physical | 26186194 | |
WDTC1_HUMAN | WDTC1 | physical | 26186194 | |
CETN2_HUMAN | CETN2 | physical | 26186194 | |
LG3BP_HUMAN | LGALS3BP | physical | 28514442 | |
CETN3_HUMAN | CETN3 | physical | 28514442 | |
CETN2_HUMAN | CETN2 | physical | 28514442 | |
WDTC1_HUMAN | WDTC1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
614923 | Branched-chain ketoacid dehydrogenase kinase deficiency (BCKDKD) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-184; LYS-192; LYS-233 ANDLYS-245, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33, AND MASSSPECTROMETRY. |